MeSH D006947 - hyperkalemia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| AstraZeneca | Sodium zirconium cyclosilicate | Lokelma | 2032-02-10 | 2018-05-18 | $238 M | Q1/21-Q2/23 |
| Vifor | Patiromer | Veltassa | 2017-07-19 |
Clinical Trials
Historical Success Rate
Phase 1
25%1/4
Phase 2
78%7/9
Phase 3
58%7/12
Approved: 5Overall Success rate: 11%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use